维普中文期刊产品整合服务
45篇 您的检索式:作者名="FREI CR"
    题名 作者 年代 出处 被引量
1Health economics of use fluoroquinolones to treat patients with community - acquired pneumonia 显示文摘Restrepo MI Frei CR 2010Am J Med2010,123,4:1
2Antimicrobial breakpoints for gram-negarive aerobic bacteria based on pharmacokinetic-pharmacodynamic models with Monte Carlo simulation显示文摘Frei CR Wiederhold NP Burgess DS 2008Antimicrob Chemother2008,61,3:1
3The United States' progress toward eliminating catheter-related bloodstream infections: incidence, mortality,and hospital length of stay from 1996 to 2008 显示文摘Daniels KR Frei CR 2013Am J Infect Controh2013,41,2:1
4Safety,pharmacokinetics and pharmacodynamics of GS-9620,an oral Toll-like receptor 7 agonist显示文摘Lopatin U Wolfgang G Tumas D Frey CR Ohmstede C Hesselgesser J Kearney B Moorehead L Subramanian G M McHutchison J G 2013Antivir Ther2013,18,3:1
5Guidelineconcordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the in-tensive care unit显示文摘Frei CR Attridge RT Mortensen EM 2010Clin Ther2010,32,2:1
6A clinical pathway for com- munity acquired pneumonia: an observational cohort study 显示文摘Frei CR Bell AM Traugott KA 2011BMC Infect Dis2011,11,:1
7Pharmacodynamic analysis of ceftriaxone,gatifloxacin,and levofloxacin against Streptococcus pneumoniae with the use of Monte Carlo simulation显示文摘FREI CR BURGESS DS 2005Pharmacotherapy2005,25,9:1
8A clinical pathway forcommunity- acquired pneumonia: an observational cohort study显示文摘Frei CR Bell AM Traugott KA 2011BMC Infectious Diseases2011,6,11:1
9Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit显示文摘Frei CR Attridge RT Mortensen EM 2010Clin Ther2010,32,2:1
10Antimicrobial breakpoints for gram-negative aerobic bacteria based on pharmacokinetic-pharmacodynamic models with Monte Carlo simulation显示文摘Frei CR Wiederhold NP Burgess DS 2008J Antimicrob Chemother2008,61,3:1
11Cost effectiveness of 4 empiric antimi erobial regimens in patients with communily acquired pneumo nia显示文摘Frei CR Burgess DS 2005Formulary2005,156,29:1
12A clinical pathway for commu- nity-acquired pneumonia: an observational cohort study 显示文摘Frei CR Bell AM Trangott KA 2011BMC Infect Dis2011,11,7:1
13Pharmacodynamics of intermittent and continuous infusion piperacillin/tazobactam And cefepim against beta-lactamase-producing organisms显示文摘Reese AM Frei CR Burgess DS 2005Antimicrob Agents2005,26,2:1
14Once-daily amikacin dosing in burn patients treated with continuous venovenous hemofiltration显示文摘Akers KS Cota JM Frei CR 0,,:1
15Antimicrobial breakpoints for gram- negative aerobic bacteria based on pharmacokinetic-phar- macodynamic models with Monte Carlo simulation显示文摘Frei CR Wiederhold NP Burgess DS 2008JAC2008,61,3:1
16The United States' progress toward eliminating catheter-re- lated bloodstream infections: Incidence, mortality, and hospital length of stay from 1996 to 2008显示文摘Daniels KR Frei CR 2013American Journal of In- fection Control2013,41,2:1
17Once-daily amikacin dosing in burn patients treated with continuous venove- nous hemofiltration显示文摘Akers KS Cota JM Frei CR 20114ntimicrob Agents Chemother2011,55,10:1
18Zaleplon and triazolam in humans:acute behavioral effects and abuse protential显示文摘Rush CR Frey JM Griffiths RR 1999Psychopharmacology1999,145,:1
19Role of cathepsin A and lysosomes in the intracellular activation of novel antipapillomavirus agent显示文摘Birkus G Kutty N Frey CR 2011Antimicrob Agents Chemother2011,55,5:1
20Pharmacodynamics of intermittent and continuous infusion piperacillin/tazobactam and cefepime against extended-spectrum beta-lactamase- producing organisms显示文摘Reese AM Frei CR Burgess DS 2005Int J Antimicrob Agents2005,26,2:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费